Global Oncology Biomarker Testing Practices Study

We are looking to engage experts with insights on the global oncology biomarker testing landscape. Through this engagement, we would like to speak with oncologists and pathologists who treat and/or perform biomarker testing for the following cancer indications: lung, breast, colorectal, head and neck, sarcoma, ovarian, heme, prostate. We would be offering an honorarium for a 45-60 minute phone call. All responses provided will remain anonymized and aggregated.